Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600222'
s Days Payable Range Over the Past 10 Years
Min: 54.49 Med: 79.48 Max: 123.57
Current: 91.44
During the past 13 years, Henan Taloph Pharmaceutical Stock Co's highest Days Payable was 123.57. The lowest was 54.49. And the median was 79.48.
SHSE:600222's Days Payable is ranked better than 50.81% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:600222: 91.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Taloph Pharmaceutical Stock Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henan Taloph Pharmaceutical Stock Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's Days Payable falls into.
Henan Taloph Pharmaceutical Stock Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Taloph Pharmaceutical Stock Co (SHSE:600222) has a Days Payable of 120.45 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Henan Taloph Pharmaceutical Stock Co and its competitors. This is 52% above median its historical median of 79.48. Over the past decade, Henan Taloph Pharmaceutical Stock Co's Days Payable has ranged from 54.49 to 123.57. According to the industry distribution chart, Henan Taloph Pharmaceutical Stock Co ranks #456 out of 927 companies in the Drug Manufacturers industry, placing it in the top 49.2%.
Is Henan Taloph Pharmaceutical Stock Co's Days Payable too high?
Henan Taloph Pharmaceutical Stock Co's current Days Payable of 120.45 is 52% above median its 10-year median of 79.48. Over the past 10 years, this metric has ranged from a low of 54.49 to a high of 123.57. The Drug Manufacturers industry median Days Payable is 90.38. Henan Taloph Pharmaceutical Stock Co's value of 120.45 is 33.3% above this industry median. Based on the distribution chart, Henan Taloph Pharmaceutical Stock Co ranks #456 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Henan Taloph Pharmaceutical Stock Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Henan Taloph Pharmaceutical Stock Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Henan Taloph Pharmaceutical Stock Co ranks #456 out of 927 companies for Days Payable. This puts Henan Taloph Pharmaceutical Stock Co in the upper half of its industry. The industry median Days Payable is 90.38. Henan Taloph Pharmaceutical Stock Co's value of 120.45 is 33.3% above this benchmark. Historically, Henan Taloph Pharmaceutical Stock Co's own Days Payable has ranged from 54.49 to 123.57 over the past decade. While the company's 10-year median is 79.48 vs. the industry median of 90.38, Henan Taloph Pharmaceutical Stock Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henan Taloph Pharmaceutical Stock Co's current Days Payable of 120.45 is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Henan Taloph Pharmaceutical Stock Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henan Taloph Pharmaceutical Stock Co's current Days Payable is 120.45, which is 52% above median its own 10-year median of 79.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Taloph Pharmaceutical Stock Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Taloph Pharmaceutical Stock Co (SHSE:600222) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.92, compared to a current price of ¥7.45 — trading 51.4% above its estimated fair value. The current Days Payable is 120.45, which is 52% above median its 10-year median of 79.48 and 33.3% above the Drug Manufacturers industry median of 90.38. Henan Taloph Pharmaceutical Stock Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Henan Taloph Pharmaceutical Stock Co (SHSE:600222), the current Days Payable is 120.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Overvalued in 2026?
Based on GuruFocus' analysis, Henan Taloph Pharmaceutical Stock Co stock appears to be overvalued.
The current stock price of ¥7.45 is trading 51.4% above its estimated GF Value™ of ¥4.92.
GuruFocus considers Henan Taloph Pharmaceutical Stock Co to be Significantly Overvalued.
Key valuation signals for SHSE:600222:
Days Payable: 120.45 (52% above median its 10-year median of 79.48)
GF Value™: ¥4.92 vs. price of ¥7.45 (51.4% above fair value)
Industry Position: 33.3% above the Drug Manufacturers median (#456 of 927)
No single metric tells the full story. See the SHSE:600222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henan Taloph Pharmaceutical Stock Co Business Description
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in pharmaceutical manufacturing and pharmaceutical research and development services, including pharmaceutical preparations, Chinese herbal medicine slices, and pharmaceutical research and development services. The company's pharmaceutical preparation business is mainly based on oral Chinese medicine preparations, and its treatment areas cover the respiratory system, cardiovascular and cerebrovascular system, digestive system, and nervous system.
58GF Score
Get the complete analysis for SHSE:600222
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600222 has been successfully added to your 
